NCT06376734View on ClinicalTrials.gov

Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness

PHASE2RecruitingINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

June 1, 2029

Study Completion Date

June 1, 2030

Conditions
Major Depressive DisorderObsessive-Compulsive DisorderSchizophreniaGeneralized Anxiety DisorderMood DisordersPsychiatric DisorderMental DisorderDepression, Anxiety
Interventions
DEVICE

Transcranial magnetic stimulation

Accelerated TMS will be provided for 2 days using the same dosing regimen as the FDA-cleared SAINT protocol, ten 9-minute treatments per day.

Trial Locations (2)

94087

NOT_YET_RECRUITING

Acacia Clinics, Sunnyvale

02115

RECRUITING

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Brigham and Women's Hospital

OTHER